Quiz

Article

NeurologyLive® Brain Games: October 29, 2023

Author(s):

Test your neurology knowledge with NeurologyLive®'s weekly quiz series, featuring questions on a variety of clinical and historical neurology topics. This week's topic is ataxias.

Welcome to NeurologyLive® Brain Games! This weekly quiz series, which goes live every Sunday morning, will feature questions on a variety of clinical and historical neurology topics, written by physicians, clinicians, and experts in the fields of neurological care and advocacy.

Test your mettle each week with 3 questions that cover a variety of aspects in the field of neurology, with a focus on dementia and Alzheimer disease, epilepsy and seizure disorders, headache and migraine, movement disorders, multiple sclerosis, neuromuscular disorders, sleep disorders, and stroke and cerebrovascular disease.

This week's questions include the theme of ataxias.

Click here to check out the prior iterations of Brain Games.

Interested in submitting quiz questions? Contact our associate editorial director, Matt Hoffman, via email: mhoffman@neurologylive.com.

Spinocerebellar Ataxia type 3, also known as Machado-Joseph disease, is caused by the expansion of a repeated DNA sequence within a specific gene. Which type of genetic mutation underlies this ataxia?


Which subtype of autosomal recessive ataxia is characterized by the absence of cerebellar Purkinje cells and is caused by mutations in the gene that encodes a protein involved in the transport of copper?


What is the most common form of autosomal dominant cerebellar ataxia characterized by a notable anticipation phenomenon, where symptoms tend to start at an earlier age and are more severe in successive generations?


How did you do on this week's quiz? Let us know with a response to the poll below. Don't forget to share and compare your results with your friends!

How many questions did you get correct?

One
Two
Three

Related Videos
Gil Rabinovici, MD
MaryAnn Mays, MD
Henri Ford, MD, MHA
Gil Rabinovici, MD
© 2024 MJH Life Sciences

All rights reserved.